SLC5A2 and type 2 diabetes mellitus: As many people with early‐stage CKD are cared for in primary care, supporting primary care teams in implementing the key elements of the guidelines (lifestyle, BP and glycaemic control, and the use of RASi, SGLT2 inhibitors and statins) is crucial to improving the outcomes and reducing the healthcare burden of CKD in people living with type 2 diabetes.